CDC20 and prostate carcinoma: Examination of multiple prostate cancer cohorts reveals that CDC20 interacts with GSDME and undergoes ubiquitination-mediated protein hydrolysis to negatively regulate tumor cell pyroptosis.305 The CDC20 small molecule inhibitor apcin exhibits synergistic effects with anti-PD-1 immunotherapy.